Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes

Acta Ophthalmologica

Volumn 89, Issue 3, 2011, Pages 222-228

  Abu El Asrar, Ahmed M ^a,d   Struyf, Sofie ^b   Verbeke, Hannelien ^b   Van Damme, Jo ^b   Geboes, Karel ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

diabetic retinopathy; endothelial progenitor cells; monocytes; stromal cell derived factor 1; vasculogenesis

Indexed keywords

CD133 ANTIGEN; CD14 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIAL PROGENITOR CELL; EPIRETINAL MEMBRANE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION;

ANTIGENS, CD; ANTIGENS, CD14; BONE MARROW CELLS; CHEMOKINE CXCL12; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPIRETINAL MEMBRANE; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; PEPTIDES; RECEPTORS, CXCR4; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79954986853     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01700.x     Document Type: Article

References (25)

1. Abu El-Asrar AM, Struyf S, Van Damme J, &, Geboes K, (2008): Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol 92: 699-704. (Pubitemid 351684185)
2. Aghi M, Cohen KS, Klein RJ, Scadden DT, &, Chiocca EA, (2006): Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 66: 9054-9064. (Pubitemid 44521124)
3. Asahara T, Murohara T, Sullivan A, et al., (1997): Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967. (Pubitemid 27087709)
4. + endothelial cell progenitors. Arterioscler Thromb Vasc Biol 26: 758-764. (Pubitemid 43732148)
5. Burns JM, Summers BC, Wang Y, et al., (2006): A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203: 2201-2213. (Pubitemid 44352240)
6. Butler JM, Guthrie SM, Koc M, et al., (2005): SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 115: 86-93. (Pubitemid 40385508)
7. De Falco E, Porcelli D, Torella AR, et al., (2004): SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482. (Pubitemid 39564415)
8. Dome B, Dobos J, Tovari J, et al., (2008): Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 73A: 186-193. (Pubitemid 351323747)
9. - blood derived human endothelial cell progenitors. Stem Cells 19: 304-312. (Pubitemid 32721097)
10. Hilbe W, Dirnhofer S, Oberwasserlechner F, et al., (2004): CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57: 965-969. (Pubitemid 39208249)
11. Igreja C, Courinha M, CachaÃo AS, et al., (2007): Characterization and clinical relevance of circulating and biopsy-derived enedothelial progenitor cells in lymphoma patients. Haematologica 92: 469-477. (Pubitemid 350144292)
12. + cells. Ann Hematol 84: 417-422. (Pubitemid 40867916)
13. Lima e Silva R, Shen J, Hackett SF, et al., (2007): The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J 21: 3219-3230. (Pubitemid 47565540)
14. Mizrak D, Brittan M, &, Alison MR, (2008): CD133: molecule of the moment. J Pathol 214: 3-9.
15. Murayama T, Tepper OM, Silver M, et al., (2002): Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 30: 967-972. (Pubitemid 34838899)
16. Murphy PM, Baggiolini M, Charo IF, et al., (2000): International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52: 145-176. (Pubitemid 30127598)
17. Peichev M, Naiyer AJ, Pereira D, et al., (2000): Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958. (Pubitemid 30062717)
18. + cells. Br J Haematol 115: 186-194. (Pubitemid 32995115)
19. Rafii S, &, Lyden D, (2003): Therapeutic stem progenitor cell transplantation for organ vascularization and regeneraton. Nat Med 9: 702-712. (Pubitemid 36749219)
20. Reddy K, Zhou Z, Jia SF, et al., (2008): Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. Int J Cancer 123: 831-837. (Pubitemid 352032409)
21. Santos SCR, Miguel C, Domingues I, et al., (2007): VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp Cell Res 313: 1561-1574. (Pubitemid 46589434)
22. Shi Q, Rafi S, Wu MH, et al., (1998): Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367. (Pubitemid 28323695)
23. + cells to endothelial progenitor cells. Circulation 117: 206-215.
24. Walter DH, Haendeler J, Reinhold J, et al., (2005): Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97: 1142-1151.
25. Yamaguchi J, Kusano KF, Masuo O, et al., (2003): Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328. (Pubitemid 36314418)